Ixazomib Citrate Patent Expiration
Ixazomib Citrate is Used for treating multiple myeloma in patients who have received at least one prior therapy. It was first introduced by Takeda Pharmaceuticals Usa Inc
Ixazomib Citrate Patents
Given below is the list of patents protecting Ixazomib Citrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ninlaro | US7442830 | Proteasome inhibitors | Nov 20, 2029 | Takeda Pharms Usa |
| Ninlaro | US8859504 | Boronate ester compounds and pharmaceutical compositions thereof | Jun 16, 2029 | Takeda Pharms Usa |
| Ninlaro | US9175017 | Boronate ester compounds and pharmaceutical compositions thereof | Jun 16, 2029 | Takeda Pharms Usa |
| Ninlaro | US7687662 | Proteasome inhibitors | Aug 06, 2027 | Takeda Pharms Usa |
| Ninlaro | US8003819 | Proteasome inhibitors | Aug 06, 2027 | Takeda Pharms Usa |
| Ninlaro | US8530694 | Proteasome inhibitors | Aug 06, 2027 | Takeda Pharms Usa |
| Ninlaro | US8871745 | Proteasome inhibitors | Aug 06, 2027 | Takeda Pharms Usa |
| Ninlaro | US8546608 | Proteasome inhibitors and methods of using the same |
Aug 12, 2024
(Expired) | Takeda Pharms Usa |
| Ninlaro | US9233115 | Proteasome inhibitors and methods of using the same |
Aug 12, 2024
(Expired) | Takeda Pharms Usa |
Ixazomib Citrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List